Showing results (1311-1320 of 1,403) with videos related to

Sort By:
Pageof 141
Analytical Chemistry|February 25, 2011
Simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic rangeDavid M Rissin, David R Fournier, Tomasz Piech, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2009
A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumorsGeorge D Demetri, Paolo G Casali, Jean-Yves Blay, et al.
European Journal of Cancer Care|August 3, 2021
Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa)Martin Eichler, Daniel Pink, Franka Menge, et al.
Emerging Infectious Diseases|June 21, 2021
Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement HomeClaudia Schulz, Claudia Wylezich, Kerstin Wernike, et al.
Journal of Immunological Methods|August 9, 2011
Single molecule measurements of tumor necrosis factor α and interleukin-6 in the plasma of patients with Crohn's diseaseLinan Song, David W Hanlon, Lei Chang, et al.
Cancer|April 17, 2014
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinibHeikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, et al.
Viruses|February 9, 2021
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme ImmunoassaysGregory J Walker, Zin Naing, Alberto Ospina Stella, et al.
Emerging Infectious Diseases|July 24, 2023
Detection of Hantavirus during the COVID-19 Pandemic, Arizona, USA, 2020Gavriella Hecht, Ariella P Dale, Irene Ruberto, et al.
Dermatology and Therapy|May 2, 2024
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)Eric L Simpson, Vimal H Prajapati, Yael A Leshem, et al.
Acta Dermato-Venereologica|June 11, 2026
Efficacy and Safety of Nemolizumab at Week 48: Results from the Maintenance Phase of Two Global Phase 3 Pivotal Studies (ARCADIA 1&2) in Patients with Moderate-to-Severe Atopic DermatitisAndreas Wollenberg, Jonathan I Silverberg, Franz J Legat, et al.
Pageof 141